
News|Articles|August 20, 2025
Should Chest CT be Routine for Prostate Cancer Patients on Androgen Deprivation Therapy?
Author(s)Jeff Hall
Nine months after initiation of androgen deprivation therapy (ADT), prostate cancer patients with higher myocardial extracellular volume (ECV) — derived from chest contrast-enhanced CT — had over a fourfold higher risk for major adverse cardiovascular events (MACEs), according to new research.
Advertisement
Advertisement
For patients receiving androgen deprivation therapy (ADT) for prostate cancer (PCa), emerging research affirms that assessing myocardial extracellular volume (ECV) from chest contrast-enhanced computed tomography (CECT) may provide significant utility in monitoring for cardiotoxicity and predicting major adverse cardiovascular events (MACEs).
Related to this article

Emerging CT research suggests that the plexus pancreaticus capitalis 2 (PPC2) pathway or a mass with stranding morphology may significantly increase mortality risk in patients with pancreatic cancer and extra-pancreatic nerve plexus invasion (EPNI).

In the second of a two-part podcast episode, Kalpana Kanal, PhD, and Mahadevappa Mahesh, PhD, discussed the possible impact of new research showing significant declines in CT radiation dosing over the past decade, future research directions and the potential for indication-based diagnostic reference levels (DRLs) in the future.

Emerging research suggests that the benefits of photon-counting CT may be more pronounced in patients with obesity.

In the first of a two-part podcast episode, Kalpana Kanal, PhD, and Mahadevappa Mahesh, PhD, reviewed key findings from a study examining CT radiation dosing over the past decade and shared insights from their experience for ensuring optimal radiation dosing for CT scans.

In addition to providing higher SNRs in vascular structures and parenchymal organs than energy-integrating detector CT, photon-counting CT enabled an approximately 30 percent reduction in volume CT dose index (CTDIvol) for patients with obesity, according to a new study.

Newly published preclinical research signals a substantial conceptual shift with a potential role of photon-counting CT in targeting specific biological processes.
Advertisement
Advertisement

